PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 787 Posts.
    lightbulb Created with Sketch. 161
    Interestingly, it appears we had a paradoxical drug reaction (increase in OA signs) with the lower dose.

    I hope the idea of testing the 2mg/kg 1x/wk and lower doses has disappeared forever. It has been a huge time and money waster - thanks FDA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.015(6.98%)
Mkt cap ! $70.04M
Open High Low Value Volume
21.0¢ 21.0¢ 20.0¢ $201.6K 994.6K

Buyers (Bids)

No. Vol. Price($)
15 429247 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 13806 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.